Global Phosphodiesterase Inhibitor Market Research Report Forecast 2017 to 2022

December 2017 | 103 pages | ID: GDAE72F338CEN
S&P Consulting

Abstracts

Delivery of the Report will take 2-3 working days once order is placed.

The Global Phosphodiesterase Inhibitor Market Research Report Forecast 2017-2022 is a valuable source of insightful data for business strategists. It provides the Phosphodiesterase Inhibitor industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Phosphodiesterase Inhibitor market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

Global Phosphodiesterase Inhibitor Market: Regional Segment Analysis
North America
Europe
China
Japan
Southeast Asia
India

The Major players reported in the market include:
Actelion Pharmaceuticals
United Therapeutics Corporation
Gilead sciences
Bayer AG
SteadyMed
GlaxoSmithKline
Pfizer
Reata Pharmaceuticals
Arena Pharmaceuticals

Global Phosphodiesterase Inhibitor Market: Product Segment Analysis
Type 1
Type 2
Type 3


Global Phosphodiesterase Inhibitor Market: Application Segment Analysis
Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

CHAPTER 1 PHOSPHODIESTERASE INHIBITOR MARKET OVERVIEW

1.1 Product Overview and Scope of Phosphodiesterase Inhibitor
1.2 Phosphodiesterase Inhibitor Market Segmentation by Type
  1.2.1 Global Production Market Share of Phosphodiesterase Inhibitor by Type in 2016
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Phosphodiesterase Inhibitor Market Segmentation by Application
  1.3.1 Phosphodiesterase Inhibitor Consumption Market Share by Application in 2016
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Phosphodiesterase Inhibitor Market Segmentation by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India
1.5 Global Market Size (Value) of Phosphodiesterase Inhibitor (2012-2022)

CHAPTER 2 GLOBAL ECONOMIC IMPACT ON PHOSPHODIESTERASE INHIBITOR INDUSTRY

2.1 Global Macroeconomic Environment Analysis
  2.1.1 Global Macroeconomic Analysis
  2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

CHAPTER 3 GLOBAL PHOSPHODIESTERASE INHIBITOR MARKET COMPETITION BY MANUFACTURERS

3.1 Global Phosphodiesterase Inhibitor Production and Share by Manufacturers (2015 and 2016)
3.2 Global Phosphodiesterase Inhibitor Revenue and Share by Manufacturers (2015 and 2016)
3.3 Global Phosphodiesterase Inhibitor Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Phosphodiesterase Inhibitor Manufacturing Base Distribution, Production Area and Product Type
3.5 Phosphodiesterase Inhibitor Market Competitive Situation and Trends
  3.5.1 Phosphodiesterase Inhibitor Market Concentration Rate
  3.5.2 Phosphodiesterase Inhibitor Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 GLOBAL PHOSPHODIESTERASE INHIBITOR PRODUCTION, REVENUE (VALUE) BY REGION (2012-2017)

4.1 Global Phosphodiesterase Inhibitor Production by Region (2012-2017)
4.2 Global Phosphodiesterase Inhibitor Production Market Share by Region (2012-2017)
4.3 Global Phosphodiesterase Inhibitor Revenue (Value) and Market Share by Region (2012-2017)
4.4 Global Phosphodiesterase Inhibitor Production, Revenue, Price and Gross Margin (2012-2017)
4.5 North America Phosphodiesterase Inhibitor Production, Revenue, Price and Gross Margin (2012-2017)
4.6 Europe Phosphodiesterase Inhibitor Production, Revenue, Price and Gross Margin (2012-2017)
4.7 China Phosphodiesterase Inhibitor Production, Revenue, Price and Gross Margin (2012-2017)
4.8 Japan Phosphodiesterase Inhibitor Production, Revenue, Price and Gross Margin (2012-2017)
4.9 Southeast Asia Phosphodiesterase Inhibitor Production, Revenue, Price and Gross Margin (2012-2017)
4.10 India Phosphodiesterase Inhibitor Production, Revenue, Price and Gross Margin (2012-2017)

CHAPTER 5 GLOBAL PHOSPHODIESTERASE INHIBITOR SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2012-2017)

5.1 Global Phosphodiesterase Inhibitor Consumption by Regions (2012-2017)
5.2 North America Phosphodiesterase Inhibitor Production, Consumption, Export, Import by Regions (2012-2017)
5.3 Europe Phosphodiesterase Inhibitor Production, Consumption, Export, Import by Regions (2012-2017)
5.4 China Phosphodiesterase Inhibitor Production, Consumption, Export, Import by Regions (2012-2017)
5.5 Japan Phosphodiesterase Inhibitor Production, Consumption, Export, Import by Regions (2012-2017)
5.6 Southeast Asia Phosphodiesterase Inhibitor Production, Consumption, Export, Import by Regions (2012-2017)
5.7 India Phosphodiesterase Inhibitor Production, Consumption, Export, Import by Regions (2012-2017)

CHAPTER 6 GLOBAL PHOSPHODIESTERASE INHIBITOR PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

6.1 Global Phosphodiesterase Inhibitor Production and Market Share by Type (2012-2017)
6.2 Global Phosphodiesterase Inhibitor Revenue and Market Share by Type (2012-2017)
6.3 Global Phosphodiesterase Inhibitor Price by Type (2012-2017)
6.4 Global Phosphodiesterase Inhibitor Production Growth by Type (2012-2017)

CHAPTER 7 GLOBAL PHOSPHODIESTERASE INHIBITOR MARKET ANALYSIS BY APPLICATION

7.1 Global Phosphodiesterase Inhibitor Consumption and Market Share by Application (2012-2017)
7.2 Global Phosphodiesterase Inhibitor Consumption Growth Rate by Application (2012-2017)
7.3 Market Drivers and Opportunities
  7.3.1 Potential Applications
  7.3.2 Emerging Markets/Countries

CHAPTER 8 GLOBAL PHOSPHODIESTERASE INHIBITOR MANUFACTURERS ANALYSIS

8.1 Actelion Pharmaceuticals
  8.1.1 Company Basic Information, Manufacturing Base and Competitors
  8.1.2 Product Type, Application and Specification
  8.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.1.4 Business Overview
8.2 United Therapeutics Corporation
  8.2.1 Company Basic Information, Manufacturing Base and Competitors
  8.2.2 Product Type, Application and Specification
  8.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.2.4 Business Overview
8.3 Gilead sciences
  8.3.1 Company Basic Information, Manufacturing Base and Competitors
  8.3.2 Product Type, Application and Specification
  8.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.3.4 Business Overview
8.4 Bayer AG
  8.4.1 Company Basic Information, Manufacturing Base and Competitors
  8.4.2 Product Type, Application and Specification
  8.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.4.4 Business Overview
8.5 SteadyMed
  8.5.1 Company Basic Information, Manufacturing Base and Competitors
  8.5.2 Product Type, Application and Specification
  8.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.5.4 Business Overview
8.6 GlaxoSmithKline
  8.6.1 Company Basic Information, Manufacturing Base and Competitors
  8.6.2 Product Type, Application and Specification
  8.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.6.4 Business Overview
8.7 Pfizer
  8.7.1 Company Basic Information, Manufacturing Base and Competitors
  8.7.2 Product Type, Application and Specification
  8.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.7.4 Business Overview
8.8 Reata Pharmaceuticals
  8.8.1 Company Basic Information, Manufacturing Base and Competitors
  8.8.2 Product Type, Application and Specification
  8.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.8.4 Business Overview
8.9 Arena Pharmaceuticals
  8.9.1 Company Basic Information, Manufacturing Base and Competitors
  8.9.2 Product Type, Application and Specification
  8.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.9.4 Business Overview

CHAPTER 9 PHOSPHODIESTERASE INHIBITOR MANUFACTURING COST ANALYSIS

9.1 Phosphodiesterase Inhibitor Key Raw Materials Analysis
  9.1.1 Key Raw Materials
  9.1.2 Price Trend of Key Raw Materials
  9.1.3 Key Suppliers of Raw Materials
  9.1.4 Market Concentration Rate of Raw Materials
9.2 Proportion of Manufacturing Cost Structure
  9.2.1 Raw Materials
  9.2.2 Labor Cost
  9.2.3 Manufacturing Expenses
9.3 Manufacturing Process Analysis of Phosphodiesterase Inhibitor

CHAPTER 10 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

10.1 Phosphodiesterase Inhibitor Industrial Chain Analysis
10.2 Upstream Raw Materials Sourcing
10.3 Raw Materials Sources of Phosphodiesterase Inhibitor Major Manufacturers in 2016
10.4 Downstream Buyers

CHAPTER 11 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

11.1 Marketing Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
  11.2.1 Pricing Strategy
  11.2.2 Brand Strategy
  11.2.3 Target Client
11.3 Distributors/Traders List

CHAPTER 12 MARKET EFFECT FACTORS ANALYSIS

12.1 Technology Progress/Risk
  12.1.1 Substitutes Threat
  12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

CHAPTER 13 GLOBAL PHOSPHODIESTERASE INHIBITOR MARKET FORECAST (2017-2022)

13.1 Global Phosphodiesterase Inhibitor Production, Revenue Forecast (2017-2022)
13.2 Global Phosphodiesterase Inhibitor Production, Consumption Forecast by Regions (2017-2022)
13.3 Global Phosphodiesterase Inhibitor Production Forecast by Type (2017-2022)
13.4 Global Phosphodiesterase Inhibitor Consumption Forecast by Application (2017-2022)
13.5 Phosphodiesterase Inhibitor Price Forecast (2017-2022)

CHAPTER 14 APPENDIX

List Of Tables

LIST OF TABLES

Figure Picture of Phosphodiesterase Inhibitor
Figure Global Production Market Share of Phosphodiesterase Inhibitor by Type in 2016
Table Phosphodiesterase Inhibitor Consumption Market Share by Application in 2016
Figure North America Phosphodiesterase Inhibitor Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Phosphodiesterase Inhibitor Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Phosphodiesterase Inhibitor Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Phosphodiesterase Inhibitor Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Phosphodiesterase Inhibitor Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Phosphodiesterase Inhibitor Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Phosphodiesterase Inhibitor Revenue (Million UDS) and Growth Rate (2012-2022)
Table Global Phosphodiesterase Inhibitor Capacity of Key Manufacturers (2015 and 2016)
Table Global Phosphodiesterase Inhibitor Capacity Market Share by Manufacturers (2015 and 2016)
Figure Global Phosphodiesterase Inhibitor Capacity of Key Manufacturers in 2015
Figure Global Phosphodiesterase Inhibitor Capacity of Key Manufacturers in 2016
Table Global Phosphodiesterase Inhibitor Production of Key Manufacturers (2015 and 2016)
Table Global Phosphodiesterase Inhibitor Production Share by Manufacturers (2015 and 2016)
Figure 2015 Phosphodiesterase Inhibitor Production Share by Manufacturers
Figure 2016 Phosphodiesterase Inhibitor Production Share by Manufacturers
Table Global Phosphodiesterase Inhibitor Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Phosphodiesterase Inhibitor Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Phosphodiesterase Inhibitor Revenue Share by Manufacturers
Table 2016 Global Phosphodiesterase Inhibitor Revenue Share by Manufacturers
Table Global Market Phosphodiesterase Inhibitor Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Phosphodiesterase Inhibitor Average Price of Key Manufacturers in 2016
Table Manufacturers Phosphodiesterase Inhibitor Manufacturing Base Distribution and Sales Area
Table Manufacturers Phosphodiesterase Inhibitor Product Type
Figure Phosphodiesterase Inhibitor Market Share of Top 3 Manufacturers
Figure Phosphodiesterase Inhibitor Market Share of Top 5 Manufacturers
Table Global Phosphodiesterase Inhibitor Capacity by Regions (2012-2017)
Figure Global Phosphodiesterase Inhibitor Capacity Market Share by Regions (2012-2017)
Figure Global Phosphodiesterase Inhibitor Capacity Market Share by Regions (2012-2017)
Figure 2015 Global Phosphodiesterase Inhibitor Capacity Market Share by Regions
Table Global Phosphodiesterase Inhibitor Production by Regions (2012-2017)
Figure Global Phosphodiesterase Inhibitor Production and Market Share by Regions (2012-2017)
Figure Global Phosphodiesterase Inhibitor Production Market Share by Regions (2012-2017)
Figure 2015 Global Phosphodiesterase Inhibitor Production Market Share by Regions
Table Global Phosphodiesterase Inhibitor Revenue by Regions (2012-2017)
Table Global Phosphodiesterase Inhibitor Revenue Market Share by Regions (2012-2017)
Table 2015 Global Phosphodiesterase Inhibitor Revenue Market Share by Regions
Table Global Phosphodiesterase Inhibitor Production, Revenue, Price and Gross Margin (2012-2017)
Table North America Phosphodiesterase Inhibitor Production, Revenue, Price and Gross Margin (2012-2017)
Table Europe Phosphodiesterase Inhibitor Production, Revenue, Price and Gross Margin (2012-2017)
Table China Phosphodiesterase Inhibitor Production, Revenue, Price and Gross Margin (2012-2017)
Table Japan Phosphodiesterase Inhibitor Production, Revenue, Price and Gross Margin (2012-2017)
Table Southeast Asia Phosphodiesterase Inhibitor Production, Revenue, Price and Gross Margin (2012-2017)
Table India Phosphodiesterase Inhibitor Production, Revenue, Price and Gross Margin (2012-2017)
Table Global Phosphodiesterase Inhibitor Consumption Market by Regions (2012-2017)
Table Global Phosphodiesterase Inhibitor Consumption Market Share by Regions (2012-2017)
Figure Global Phosphodiesterase Inhibitor Consumption Market Share by Regions (2012-2017)
Figure 2015 Global Phosphodiesterase Inhibitor Consumption Market Share by Regions
Table North America Phosphodiesterase Inhibitor Production, Consumption, Import & Export (2012-2017)
Table Europe Phosphodiesterase Inhibitor Production, Consumption, Import & Export (2012-2017)
Table China Phosphodiesterase Inhibitor Production, Consumption, Import & Export (2012-2017)
Table Japan Phosphodiesterase Inhibitor Production, Consumption, Import & Export (2012-2017)
Table Southeast Asia Phosphodiesterase Inhibitor Production, Consumption, Import & Export (2012-2017)
Table India Phosphodiesterase Inhibitor Production, Consumption, Import & Export (2012-2017)
Table Global Phosphodiesterase Inhibitor Production by Type (2012-2017)
Table Global Phosphodiesterase Inhibitor Production Share by Type (2012-2017)
Figure Production Market Share of Phosphodiesterase Inhibitor by Type (2012-2017)
Figure 2015 Production Market Share of Phosphodiesterase Inhibitor by Type
Table Global Phosphodiesterase Inhibitor Revenue by Type (2012-2017)
Table Global Phosphodiesterase Inhibitor Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Phosphodiesterase Inhibitor by Type (2012-2017)
Figure 2015 Revenue Market Share of Phosphodiesterase Inhibitor by Type
Table Global Phosphodiesterase Inhibitor Price by Type (2012-2017)
Figure Global Phosphodiesterase Inhibitor Production Growth by Type (2012-2017)
Table Global Phosphodiesterase Inhibitor Consumption by Application (2012-2017)
Table Global Phosphodiesterase Inhibitor Consumption Market Share by Application (2012-2017)
Figure Global Phosphodiesterase Inhibitor Consumption Market Share by Application in 2015
Table Global Phosphodiesterase Inhibitor Consumption Growth Rate by Application (2012-2017)
Figure Global Phosphodiesterase Inhibitor Consumption Growth Rate by Application (2012-2017)
Table Actelion Pharmaceuticals Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Actelion Pharmaceuticals Phosphodiesterase Inhibitor Production, Revenue, Price and Gross Margin (2012-2017)
Table Actelion Pharmaceuticals Phosphodiesterase Inhibitor Market Share (2012-2017)
Table United Therapeutics Corporation Basic Information, Manufacturing Base, Production Area and Its Competitors
Table United Therapeutics Corporation Phosphodiesterase Inhibitor Production, Revenue, Price and Gross Margin (2012-2017)
Table United Therapeutics Corporation Phosphodiesterase Inhibitor Market Share (2012-2017)
Table Gilead sciences Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Gilead sciences Phosphodiesterase Inhibitor Production, Revenue, Price and Gross Margin (2012-2017)
Table Gilead sciences Phosphodiesterase Inhibitor Market Share (2012-2017)
Table Bayer AG Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bayer AG Phosphodiesterase Inhibitor Production, Revenue, Price and Gross Margin (2012-2017)
Table Bayer AG Phosphodiesterase Inhibitor Market Share (2012-2017)
Table SteadyMed Basic Information, Manufacturing Base, Production Area and Its Competitors
Table SteadyMed Phosphodiesterase Inhibitor Production, Revenue, Price and Gross Margin (2012-2017)
Table SteadyMed Phosphodiesterase Inhibitor Market Share (2012-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Production Area and Its Competitors
Table GlaxoSmithKline Phosphodiesterase Inhibitor Production, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline Phosphodiesterase Inhibitor Market Share (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Pfizer Phosphodiesterase Inhibitor Production, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Phosphodiesterase Inhibitor Market Share (2012-2017)
Table Reata Pharmaceuticals Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Reata Pharmaceuticals Phosphodiesterase Inhibitor Production, Revenue, Price and Gross Margin (2012-2017)
Table Reata Pharmaceuticals Phosphodiesterase Inhibitor Market Share (2012-2017)
Table Arena Pharmaceuticals Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Arena Pharmaceuticals Phosphodiesterase Inhibitor Production, Revenue, Price and Gross Margin (2012-2017)
Table Arena Pharmaceuticals Phosphodiesterase Inhibitor Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Phosphodiesterase Inhibitor
Figure Manufacturing Process Analysis of Phosphodiesterase Inhibitor
Figure Phosphodiesterase Inhibitor Industrial Chain Analysis
Table Raw Materials Sources of Phosphodiesterase Inhibitor Major Manufacturers in 2016
Table Major Buyers of Phosphodiesterase Inhibitor
Table Distributors/Traders List
Figure Global Phosphodiesterase Inhibitor Production and Growth Rate Forecast (2017-2022)
Figure Global Phosphodiesterase Inhibitor Revenue and Growth Rate Forecast (2017-2022)
Table Global Phosphodiesterase Inhibitor Production Forecast by Regions (2017-2022)
Table Global Phosphodiesterase Inhibitor Consumption Forecast by Regions (2017-2022)
Table Global Phosphodiesterase Inhibitor Production Forecast by Type (2017-2022)
Table Global Phosphodiesterase Inhibitor Consumption Forecast by Application (2017-2022)

COMPANIES MENTIONED

Actelion Pharmaceuticals
United Therapeutics Corporation
Gilead sciences
Bayer AG
SteadyMed
GlaxoSmithKline
Pfizer
Reata Pharmaceuticals
Arena Pharmaceuticals
Merck